Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Matthias Lutterbeck"'
Autor:
Noemi F. Freise, Smaranda Gliga, Johannes Fischer, Nadine Lübke, Matthias Lutterbeck, Miriam Schöler, Edwin Bölke, Hans Martin Orth, Torsten Feldt, Christoph Roemmele, Dominik Wilke, Jochen Schneider, Kai Wille, Christian Hohmann, Richard Strauss, Martin Hower, Andreas Ruf, Joerg Schubert, Nora Isberner, Melanie Stecher, Lisa Pilgram, Jörg J. Vehreschild, LEOSS Study Group, Frank Hanses, Tom Luedde, Björn Jensen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Establishing the optimal treatment for COVID-19 patients remains challenging. Specifically, immunocompromised and pre-diseased patients are at high risk for severe disease course and face limited therapeutic options. Convalescent plasma (CP)
Externí odkaz:
https://doaj.org/article/2948c18af740438fb69cf9d409d8bd99
Autor:
Johannes C. Fischer, Albrecht G. Schmidt, Edwin Bölke, Markus Uhrberg, Verena Keitel, Torsten Feldt, Björn Jensen, Dieter Häussinger, Ortwin Adams, E. Marion Schneider, Vera Balz, Jürgen Enczmann, Jutta Rox, Derik Hermsen, Karin Schulze-Bosse, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Martijn van Griensven, Jan Haussmann, Balint Tamaskovics, Christian Plettenberg, Kathrin Scheckenbach, Stefanie Corradini, Alessia Pedoto, Kitti Maas, Livia Schmidt, Olaf Grebe, Irene Esposito, Anja Ehrhardt, Matthias Peiper, Bettina Alexandra Buhren, Christian Calles, Andreas Stöhr, Artur Lichtenberg, Noemi F. Freise, Matthias Lutterbeck, Amir Rezazadeh, Wilfried Budach, Christiane Matuschek
Publikováno v:
European Journal of Medical Research, Vol 26, Iss 1, Pp 1-13 (2021)
Abstract Background COVID-19, the pandemic disease caused by infection with SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study was to assess the assoc
Externí odkaz:
https://doaj.org/article/3b05bd6a73be4386b794f539276e2c00
Autor:
Bjoern Jensen, Nadine Luebke, Torsten Feldt, Verena Keitel, Timo Brandenburger, Detlef Kindgen-Milles, Matthias Lutterbeck, Noemi F Freise, David Schoeler, Rainer Haas, Alexander Dilthey, Ortwin Adams, Andreas Walker, Joerg Timm, Tom Luedde
Publikováno v:
The Lancet Regional Health. Europe, Vol 8, Iss , Pp 100164- (2021)
Background: Monoclonal antibodies (mAb) have been introduced as a promising new therapeutic approach against SARS-CoV-2. At present, there is little experience regarding their clinical effects in patient populations underrepresented in clinical trial
Externí odkaz:
https://doaj.org/article/d3595f30d669480c8f5c3c658a8a8343
Autor:
Balint Tamaskovics, E. Marion Schneider, Johannes C. Fischer, Vera Balz, Torsten Feldt, Irene Esposito, Kitti Maas, Anja Erhardt, C Plettenberg, Alessia Pedoto, Wolfram T. Knoefel, Martijn van Griensven, Karin Schulze-Bosse, Albrecht G. Schmidt, Derik Hermsen, Andreas Stöhr, Wilfried Budach, Björn Jensen, Christian Calles, Jan Haussmann, Livia Schmidt, Matthias Lutterbeck, Dieter Häussinger, Artur Lichtenberg, Jutta Rox, Olaf Grebe, Amir Rezazadeh, Stefanie Corradini, Kathrin Scheckenbach, Noemi F. Freise, Bettina Alexandra Buhren, Jürgen Enczmann, Matthias Peiper, Ortwin Adams, Verena Keitel, Detlef Kindgen-Milles, Edwin Boelke, Christiane Matuschek, Markus Uhrberg
COVID-19, the pandemic infection caused by SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study was to assess the association of COVID-19 clinical cours
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b348b304d93c64c539cd3540b7fe928
https://doi.org/10.21203/rs.3.rs-600023/v1
https://doi.org/10.21203/rs.3.rs-600023/v1
Autor:
M. Neukirchen, Matthias Lutterbeck, Ina Grau, Peter Kienbaum, Daniel Schlieper, Joachim Cordes, J Schwartz, Patrick van Caster, Eduard Falk
Publikováno v:
BMC Palliative Care
BMC Palliative Care, Vol 19, Iss 1, Pp 1-15 (2020)
BMC Palliative Care, Vol 19, Iss 1, Pp 1-15 (2020)
Background Patients in palliative care need rapid-acting pharmacological options for psychological distress. N-methyl-D-aspartate antagonist ketamine is known to have a fast onset of anti-depressant and anxiolytic action. Its S-enantiomer S-ketamine
Autor:
Ortwin Adams, Bjoern Jensen, Matthias Lutterbeck, Joerg Timm, Verena Keitel, Noemi F. Freise, Nadine Luebke, David Schoeler, Tom Luedde, Detlef Kindgen-Milles, Rainer Haas, Alexander T. Dilthey, Timo Brandenburger, Andreas Walker, Torsten Feldt
Publikováno v:
The Lancet Regional Health. Europe
The Lancet Regional Health. Europe, Vol 8, Iss, Pp 100164-(2021)
The Lancet Regional Health. Europe, Vol 8, Iss, Pp 100164-(2021)
Background Monoclonal antibodies (mAb) have been introduced as a promising new therapeutic approach against SARS-CoV-2. At present, there is little experience regarding their clinical effects in patient populations underrepresented in clinical trials
Autor:
J Schwartz, M. Neukirchen, Peter Kienbaum, Matthias Lutterbeck, E Falk, P. van Caster, Daniel Schlieper, Joachim Cordes
Publikováno v:
12. Kongress der Deutschen Gesellschaft für Palliativmedizin.
Autor:
Lars Holland, Matthias Lutterbeck, Markus Schürmann, Bernhard Lippert, Pablo J. Sanz Miguel, Olga Krizanovic, Edda C. Fusch, Lu Yin, Patrick Lax, Michael Roitzsch
Publikováno v:
Dalton Transactions. :10774
The role of the NH(3) ligands in the highly successful antitumour agents cisplatin and carboplatin is not fully understood. Suggestions that the ammonia ligands are involved in target recognition through hydrogen bond formation, e.g. with guanine-O6,
Autor:
Pablo J. Sanz Miguel, Michael Roitzsch, Lu Yin, Patrick M. Lax, Lars Holland, Olga Krizanovic, Matthias Lutterbeck, Markus Schürmann, Edda C. Fusch, Bernhard Lippert
Publikováno v:
Dalton Transactions: An International Journal of Inorganic Chemistry; Dec2009, Vol. 2009 Issue 48, p10774-10786, 13p